Kabir, Eva RahmanNasir, Naushin Sadia2021-12-262021-12-2620212021-04ID 17146047http://hdl.handle.net/10361/15764Cataloged from PDF version of thesis report.Includes bibliographical references (pages 34-49).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.This review focuses on repurposing of drugs for the treatment of noncommunicable diseases. Drug repurposing is the development of new indications for existing drugs. Noncommunicable diseases are causing large number of deaths every year. Therefore, drug repurposing is an effective strategy for the treatment of noncommunicable diseases. This review discusses the methods, benefits and challenges of drug repurposing as well as all the approved repurposed drugs for NCDs and the repurposed drugs that are awaiting approval by the FDA. Considering the challenges faced due to repurposing of drugs, some recommendations are put forward to improve the future of drug repurposing.49 pagesenBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Drug repurposingNoncommunicable diseaseMarket and data exclusivityBenefits and challengesCommunicable diseasesChronic diseases--TreatmentDrug developmentThesis